Anti-glomerular basement membrane glomerulonephritis: A morphologic study of 80 cases

American Journal of Clinical Pathology

Volumn 125, Issue 3, 2006, Pages 445-450

  Fischer, Edgar G ^a,b   Lager, Donna J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Anti glomerular basement membrane disease; Anti glomerular basement membrane glomerulonephritis; Goodpasture syndrome; Necrotizing and crescentic glomerulonephritis; Pathology; Renal biopsy

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CREATININE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN DETECTION; ANTIGLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS; ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; NECROTIC GLOMERULONEPHRITIS; PRIORITY JOURNAL;

EID: 33644659729     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/NPTP4UKV7JU3ELMQ     Document Type: Article

References (23)

1. Cohen AH, Glassock RJ. Anti-GBM glomerulonephritis including Goodpasture disease. In: Tisher CC, Brenner BM, eds. Renal Pathology. 2nd ed. Philadelphia, PA: Lippincott; 1994:524-552.
2. Meyers CM, Kalluri R, Neilson EG. Anti-glomerular basement membrane disease. In: Neilson EG, Couser WG, eds. Immunologic Renal Diseases. Philadelphia, PA: Lippincott-Raven; 1997:959-973.
3. Jennette JC. Crescentic glomerulonephritis. In: Jennette JC, Olson JL, Schwartz MM, et al, eds. Heptinstall's Pathology of the Kidney. 5th ed. Philadelphia, PA: Lippincott-Raven; 1998:625-656.
4. Wilson CB, Dixon FJ. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int. 1973;3:74-89.
5. Perez GO, Bjornsson S, Ross AH, et al. A mini-epidemic of Goodpasture's syndrome clinical and immunological studies. Nephron. 1974;13:161-173.
6. McPhaul JJ Jr, Mullins JD. Glomerulonephritis mediated by antibody to glomerular basement membrane: immunological, clinical, and histopathological characteristics. J Clin Invest. 1976;57:351-361.
7. Teague CA, Doak PB, Simpson IJ, et al. Goodpasture's syndrome: an analysis of 29 cases. Kidney Int. 1978;13:492-504.
8. Walker RG, Scheinkestel C, Becker GJ, et al. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome. Q J Med. 1985;54:75-89.
9. Savage CO, Pusey CD, Bowman C, et al. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J. 1986;292:301-304.
10. Herody M, Bobrie G, Gouarin C, et al. Anti-GBM disease: predictive value of clinical, histological and serological data. Clin Nephrol. 1993;40:249-255.
11. Merkel F, Pullig O, Marx M, et al. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases. Nephrol Dial Transplant. 1994;9:372-376.
12. Daly C, Conlon PJ, Medwar W, et al. Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience. Ren Fail. 1996;18:105-112.
13. Levy JB, Turner AN, Rees AJ, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033-1042.
14. Salama AD, Pusey CD. Immunology of anti-glomerular basement membrane disease. Curr Opin Nephrol Hypertens. 2002;11:279-286.
15. Saus J, Wieslander J, Langeveld JP, et al. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem. 1988;263:13374-13380.
16. Turner AN, Mason PJ, Brown R, et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest. 1992;89:592-601.
17. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967;126:989-1004.
18. Border WA, Baehler RW, Bhathena D, et al. IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med. 1979;91:21-25.
19. Fivush B, Melvin T, Solez K, et al. Idiopathic linear glomerular IgA deposition. Arch Pathol Lab Med. 1986;110:1189-1191.
20. Gris P, Pirson Y, Hamels J, et al. Antiglomerular basement membrane nephritis induced by IgA1 antibodies. Nephron. 1991;58:418-424.
21. Fervenza FC, Terreros D, Boutaud A, et al. Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis. 1999;34:549-555.
22. Borza DB, Neilson EG, Hudson BG. Pathogenesis of Goodpasture syndrome: a molecular perspective. Semin Nephrol. 2003;23:522-531.
23. Salama AD, Levy JB. Tolerance and autoimmunity in anti-GBM disease [editorial]. J Am Soc Nephrol. 2003;14:2988-2989.